Biotech Lab 4.0
Vaccine development by design

A revolutionary way to accelerate, control and implement processes in real time by creating intelligent networks of equipment and open data systems that govern each other.
AchilleS Vaccines Biotech Lab 4.0 is a new model of early stage development for new biopharmaceutical products, particularly those containing, or consisting of, recombinant proteins (e.g. vaccines, immuno-therapeutics, ), and a new model of pre-clinical R&D.
Our Technology
AchilleS Vaccines exploits integrated technological platforms to identify, select and develop future approaches to deliver effective products.
They Talk About Us
Latest News
-
Progetto SHASI – Intelligenza artificiale per nuovi vaccini
Siena, 04/03/2022. Intelligenza artificiale per nuovi vaccini. È questo il tema del progetto SHASI (Siena Hub Against Salmonella Infections), che si è concluso lunedì 28
-
Achilles Vaccines crea una piattaforma 4.0 con le ricerche mondiali
La start up biotech senese mette a sistema i dati sulla sperimentazione globale. L' ad Baccheschi: «Obiettivo avere dosi rapidamente e a basso costo» Riccardo Baccheschi
-
EU Malaria Fund: AchilleS Vaccines, Magnetrap, KELTIC Pharma and Sumaya receive a total of EUR 17.6 million to develop malaria vaccines, diagnostics and therapeutics.
Berlin, September 3, 2021 This week, AchilleS Vaccines S.r.l., Magnetrap SA, KELTIC Pharma Therapeutics Ltd and Sumaya Biotech GmbH & Co. KG. concluded contracts with the